Menu

Study Finds No Race or Gender Bias in Grant Peer Review

The paper’s authors say bias may nevertheless be present in other steps of the granting process.

Jun 1, 2018
Shawna Williams

ISTOCK, JACOBLUNDA study that asked experts to review real grant proposals in which the investigator’s name had been changed has found no meaningful difference in rankings based on race or gender, according to a preprint published May 25. The findings appear to contradict previous reports that found worse average grant funding outcomes for women and African-Americans than could be explained by differences in qualifications. Still, the new study’s authors write that bias may indeed be present in other aspects of the granting process.

See “NIH Funds to Tackle Sex Bias in Research”

“I’ve made a career out of studying bias and how to overcome it. I know the problem to be real. But here in this particular context, it may not be the place where the bias shows itself,” coauthor Patricia Devine of the University of Wisconsin–Madison tells Science.

The research team substituted the real names on 48 funded National Institutes of Health (NIH) proposals with fake names statistically likely to belong to either a white man, a black man, a black woman, or a white woman. They then sent the proposals to several hundred scientists who were expert in the grant’s field for review (reviewers were paid for participating, and told not to review references lest they reveal the true investigator’s name). The results revealed only tiny differences in the scores given to the proposals with different names.

See “Opinion: Fixing Science’s Human Bias”

“A name is just one factor among many ways in which your race and gender are embedded in everything you do,” such as where one’s training takes place, Raynard Kington, president of Grinnell College in Iowa, tells Science. Kington coauthored a 2011 study that found African-American scientists were 10 percent less likely to win NIH grants than white researchers, after accounting for factors such as publication record. That study has prompted efforts on NIH’s part to study and counteract bias.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.